Skip to main content
Equibles

Phil Tennant

Precigen, Inc. (PGEN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Precigen, Inc. publishes a filing, an earnings call transcript or a press release.

Get PGEN alerts

About Phil Tennant

The proxy statement of Precigen, Inc. reports total compensation of $1,229,956 for Phil Tennant in fiscal 2025, including a base salary of $510,000. Disclosed compensation is on record for 2 fiscal years. Phil Tennant has spoken on 3 earnings calls across 1 company, most recently for Precigen, Inc. on November 4, 2026. Precigen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precigen, Inc. includes Helen Sabzevari (CEO and Board Member), Helen Sabzevari, Ph.D. (CEO), Randal J. Kirk (Chairman and Board Member) and 7 others.

Phil Tennant on recent calls

“What an extraordinary year it has been for Papsimios. Just over one year after FDA approval, we have moved beyond the foundational phase of our launch and established Papsimios as the first-line standard of care for adults with RRP.”
Other, Precigen to Announce Third Quarter 2026 Financial Results and Provide Business Updates on November 4 ·
“I'm pleased to provide an update on the continued progress of our commercial launch.”
Other, Precigen, Inc. Q2 FY2026 Earnings Call ·
“I'm delighted to share the most recent progress of our launch efforts with details around the completion of Q1 and the sharp momentum we continue to see with Papzimio's launch in Q2 of this year.”
Other, Precigen, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Precigen, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Precigen, Inc. (PGEN) $510,000 $1,229,956
2024 Precigen, Inc. (PGEN) $215,769 $518,337

Recent activity